Oral

Oral capability covers prevention, rapid point-of-care diagnostics, infection control, trauma management, and rehabilitation for dental and maxillofacial injuries. It addresses oral-systemic interactions (sepsis risk, airway compromise), antimicrobial resistance and biofilms, prosthetic and soft-tissue reconstruction, and technologies tailored for austere or prolonged-field-care environments.

Technical Challenges

  • Acute dental and maxillofacial trauma (blast, penetrating, blunt) with airway and hemorrhage risks in polytrauma.

  • Biofilm formation and antimicrobial resistance complicating oral wound and implant infections.

  • Limited point-of-care diagnostics for oral pathogens and differentiation of colonization versus invasive infection.

  • Constraints of prolonged-field care: limited sterilization, power, imaging, and specialist surgical support.

Emerging Opportunities

  • Rapid, rugged, point-of-care tests for oral pathogens and antibiotic-resistance markers suitable for field use.

  • Antimicrobial coatings and wound dressings effective in saliva and contaminated oral environments.

  • Portable imaging and surgical tools for diagnosis and stabilization of mandibular, dental, and facial fractures.

  • Regenerative bone and soft-tissue solutions that enable reconstruction without sophisticated surgical suites.

Current and Emerging Technologies in Oral

Point-of-care molecular and host-response diagnostics

Rapid PCR/CRISPR and antigen platforms, combined with host-biomarker panels, to detect oral pathogens, virulence factors, and early systemic inflammatory responses at the point of injury.

Antimicrobial agents, coatings and anti-biofilm strategies

Novel antimicrobials, surface-modified implants, and enzymatic or nanoparticle approaches that disrupt biofilms and address multidrug-resistant organisms in oral wounds and prostheses.

Portable imaging, intraoral 3D scanning, and augmented surgical navigation

Low-power cone-beam CT, handheld ultrasound, and compact intraoral scanners to enable on-site diagnosis, fracture assessment, and preoperative planning in forward environments.

Regenerative biomaterials and point-of-care grafting

Osteoinductive scaffolds, growth-factor–enhanced matrices, and off-the-shelf constructs to support jaw bone and soft tissue reconstruction when evacuation is delayed.

Tele-dentistry, decision support, and AI triage

Secure telehealth platforms, image-forward consultation, and AI tools to prioritize cases, guide non-specialist providers, and integrate oral data with trauma care workflows.

Importance to Military Medicine

Combat casualty care

Oral and maxillofacial injuries can threaten airway patency, cause hemorrhage, and complicate polytrauma—requiring immediate diagnostics and stabilization.

Prolonged and austere care

Delayed evacuation elevates infection and loss-of-function risk; field-capable oral solutions sustain warfighter health until definitive care.

Force readiness and prevention

Dental readiness impacts deployability; prevention, surveillance, and rapid treatment preserve operational capability.

Civilian and dual-use impact

Technologies developed for military oral trauma and infection translate to civilian trauma centers, under-resourced clinics, and disaster response.

Alignment with the MTEC Mission

Directly advances MTEC priorities by accelerating field-ready diagnostics, therapeutics, and regenerative solutions for warfighter survival and recovery.

Supports interdisciplinary approaches across combat casualty care, infectious disease, and prolonged care portfolios emphasized by MTEC.

Enables dual-use innovations that benefit civilian healthcare while meeting DoD readiness and austere-environment requirements.

Dual-Use (Military + Civilian) Applications

Forward-deployable dental kits and hemorrhage-control products for immediate stabilization of oral bleeding and airway threats.

Point-of-care pathogen testing to guide antimicrobial selection and reduce inappropriate antibiotic use in field conditions.

Portable imaging and tele-dentistry to triage fractures, plan temporary fixation, and coordinate evacuation priorities.

Regenerative scaffolds and off-the-shelf grafts enabling reconstructive interventions when definitive surgery is delayed.

Explore MTEC Members with Oral Capabilities

MTEC members contribute expertise across diagnostics, biomaterials, device miniaturization, and clinical trial networks to translate oral technologies rapidly into practice.

Consortium collaboration accelerates integration of military requirements, regulatory strategy, and civilian partnerships to validate dual-use solutions.

Explore member profiles to identify partners with clinical, engineering, and commercialization capabilities ready to advance oral health innovations for warfighters and civilians.

65 Members with Oral capabilities.

Member
Georgia Southern University

Georgia Southern University is a vibrant institution with over 26,100 students across three campuses in Statesboro, Savannah, and Hinesville. The university offers 132 degree programs at the associate, bachelor’s, master’s, and doctorate levels, emphasizing student success, community impact, and research excellence. With a commitment to inclusivity and engagement, Georgia Southern fosters a supportive environment for diverse learners, including military-affiliated and adult students. The university is dedicated to transforming lives through education and community engagement, aligning its programs with regional needs. Additionally, Georgia Southern provides accelerated pathways for students to fast-track their master's degrees, enhancing educational opportunities. The university also emphasizes career readiness and public impact research, preparing students for successful careers and contributing to community development.

Member
FiteBac Pharma

FiteBac Technology/FiteBac Pharma's K21 uniquely targets the underlying disease state, given that most diseases involve microbial-associated inflammation and mitochondrial dysfunction. FiteBac Technology innovations stem from the work of numerous international academic research scientists. FiteBac Pharma K21 is the blockbuster antimicrobial small molecule designed to modulate biological, immunological, and metabolic systems for treating a wide range of infectious and inflammatory diseases. This patented drug substance has demonstrated the ability to safely eliminate bacterial, fungal, and viral infections, enhance innate immunity, induce mitophagy while improving mitochondrial and cellular metabolism, accelerate wound healing, and even promote the development of zebrafish and chickens, leading to increased adult mass. Rigorous research from Dr. Bhupesh Prusty's laboratory and Dr Christopher Rongo's laboratory is focused on various aspects of mitochondrial remodeling and reprograming, as well as mitochondrial-to-nuclear signaling with K21.

Member
Auburn University

Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.

Member
University of Arkansas

The Institute for Integrative & Innovative Research (I3R) at the University of Arkansas is dedicated to pioneering solutions to complex societal challenges through convergence research. With a mission to advance research excellence and stimulate economic development, I3R focuses on deploying innovations at scale through collaboration across various sectors, including academia, industry, and government.

Member
The University of Chicago

The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.

Member
Memsel

Memsel is a biotechnology research and development company dedicated to enhancing health and combatting infections through advanced phage therapies and targeted delivery systems. The company aims to transform healthcare solutions across human, animal, and plant domains, addressing critical health challenges and antibiotic resistance.

Member
Boston University

Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.

Member
Baylor University

Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.

Member
Evimero

Evimero is an interdisciplinary company focused on understanding the interactions between microorganisms and human health, agriculture, and the environment, utilizing Systems Biology and AI/ML. Evimero applies molecular principles to infectious disease and microbiome science to improve health outcomes and environmental sustainability through targeted interventions in dysbiotic microbiomes and in people with infectious disorders. Evimero has an infectious disease product pipeline including both prophylactic and diagnostic assets against common causes of Travelers' Diarrhea, including a unique approach to preventing infection with human Norovirus, enterotoxigenic E. coli (ETEC) and others. Evimero's pipeline of drugs targeting human and animal microbiomes includes early-stage assets aimed at generalized microbiome-driven inflammation and gut leak, and specific disease-targeted disorders including Parkinson Disease and Inflammatory Bowel Diseases. Evimero's platform also makes possible a suite of point-of-care diagnostics that can be used for patient cohorting (infectious diseases), risk stratification, and ultimately informing therapeutic decision-making. The nature of Evimero's platform assures a steady stream of novel assets targeting both infectious diseases and chronic disorders with roots in microbiome dysfunction.

Member
Solventum

Solventum is a healthcare company dedicated to enabling better, smarter, and safer healthcare solutions. With a legacy of innovation, Solventum focuses on improving patient outcomes through advanced medical technologies, oral care solutions, health information technology, and purification and filtration systems.

Member
University of Maryland, Baltimore

The University of Maryland, Baltimore (UMB) is Maryland’s public health, law, and human services university. It is dedicated to improving the human condition and serving the public good through education, research, clinical care, and service. UMB is the founding campus of the University System of Maryland and offers a wide range of professional degrees in health care, human services, and law.

Member
University of North Carolina Wilmington

The University of North Carolina Wilmington (UNCW) is a top doctoral and research institution located in Wilmington, North Carolina. Established in 1947, UNCW has grown to serve nearly 18,000 students and employs about 2,500 staff. The university is dedicated to providing a powerful academic experience that fosters creative inquiry, critical thinking, and thoughtful expression in a beautiful coastal setting. UNCW is committed to educational excellence, community engagement, and global connections, making it a vibrant part of the southeastern North Carolina community. UNCW also emphasizes the importance of freedom of expression and mutual respect within its diverse community.

Member
University of Missouri-Kansas City

The University of Missouri-Kansas City (UMKC) is dedicated to transforming today's learners into tomorrow's leaders through innovative education, research, and community engagement. With over 125 academic programs, UMKC fosters a diverse and inclusive environment that empowers students to achieve their goals and make a positive impact in their communities.

Member
Mayo Clinic

Mayo Clinic is the largest integrated, not-for-profit medical group practice in the world, dedicated to providing high-quality, patient-centered care. With a history of innovation spanning nearly 150 years, Mayo Clinic is committed to transforming healthcare through research, education, and compassionate care, ensuring that the best possible treatment is available to everyone.

Member
Shionogi Inc.

Since its founding in 1878, Shionogi has been dedicated to developing innovative treatments to improve the lives of patients worldwide. The company focuses on addressing global health challenges, including antimicrobial resistance and COVID-19, through a commitment to scientific excellence and strategic partnerships.

Member
Temple University

Temple University is Philadelphia’s only public university and a global center of academic excellence. It is classified as an R1 institution, indicating very high research activity, and offers over 600 academic programs across 17 diverse schools and colleges. The university is committed to providing accessible education that fosters positive change and prepares students to become leaders in their fields. Additionally, Temple emphasizes a vibrant campus life enriched by arts, culture, and a commitment to diversity and inclusivity. The university also promotes a tobacco-free environment to enhance the health and well-being of its community. Temple's athletics program further enhances student life, with 19 varsity teams competing at the NCAA Division I level, fostering school spirit and community engagement.

We are here to help

Can’t find what you’re looking for?

Projects

Technology Showcase

See All Projects

University of California San Francisco

TemPredict: AI-Driven Wearable Monitoring for Early Illness Detection and Warfighter Readiness

TemPredict: AI wearables detect early illness and health risks to support warfighter readiness.

Arizona State University

ASU Crosscutting Technologies to Enhance Military Medical Readiness and Resilience

Dr. Rachel Cassalia leads MTEC-supported efforts at ASU to shift military health from reactive care to proactive readiness through data-driven prevention.

University of Pittsburgh

Topical Metformin Lotion for Tendinopathy Prevention

University of Pittsburgh study shows topical metformin prevents overuse tendon injury. This work was sponsored through MTEC project 22-02-MPAI-014.

Theradaptive

Theradaptive’s RESTORE Trial Initiation for OsteoAdapt™ DE

Theradaptive launches RESTORE Phase I/II trial of OsteoAdapt™ DE for faster, precision bone healing in craniofacial injuries. MTEC-funded study targets improved recovery for military and civilian patients.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.